Proton beam therapy and localised prostate cancer: current status and controversies

被引:0
|
作者
J A Efstathiou
P J Gray
A L Zietman
机构
[1] Massachusetts General Hospital,Department of Radiation Oncology
[2] Harvard Medical School,undefined
来源
British Journal of Cancer | 2013年 / 108卷
关键词
proton beam; radiation; prostate cancer; quality of life; cost; evidence;
D O I
暂无
中图分类号
学科分类号
摘要
Proton therapy is a promising, but costly, treatment for prostate cancer. Theoretical physical advantages exist; yet to date, it has been shown only to be comparably safe and effective when compared with the alternatives and not necessarily superior. If clinically meaningful benefits do exist for patients, more rigorous study will be needed to detect them and society will require this to justify the investment of time and money. New technical advances in proton beam delivery coupled with shortened overall treatment times and declining device costs have the potential to make this a more cost-effective therapy in the years ahead.
引用
收藏
页码:1225 / 1230
页数:5
相关论文
共 50 条
  • [41] Current controversies on the role of lymphadenectomy for prostate cancer
    Chalouhy, Charbel
    Gurram, Sandeep
    Ghavamian, Reza
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (03) : 219 - 226
  • [42] Proton Beam Therapy for Localized Prostate Cancer: A Comparison of Passively Scattered to Intensity Modulated Proton Therapy
    Pugh, T. J.
    Gonzalez, G. Nogueras
    Choi, S.
    Mahmood, U.
    Mathai, B.
    Munsell, M.
    Sahoo, N.
    Gillin, M.
    Zhu, X.
    Lee, A. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S54 - S55
  • [43] Development and current status of proton therapy for lung cancer in Korea
    Yoon, Myonggeun
    THORACIC CANCER, 2012, 3 (01) : 1 - 7
  • [44] Proton Beam Radiation Therapy for Prostate Cancer—Is the Hype (and the Cost) Justified?
    Phillip J. Gray
    Jason A. Efstathiou
    Current Urology Reports, 2013, 14 : 199 - 208
  • [45] Fact or Fiction: Proton Beam Therapy is Primarily for Patients With Prostate Cancer
    Mehta, M. P.
    Dunn, M.
    Hoppe, B. S.
    Laramore, G. E.
    Chang, A. L.
    Vargas, C.
    Hartsell, W. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E353 - E354
  • [46] Oophorectomy in Breast Cancer—Controversies and Current Status
    Gurpreet Singh
    Indian Journal of Surgery, 2012, 74 : 210 - 212
  • [48] Antisense Therapy: Current Status in Prostate Cancer and Other Malignancies
    Martin Gleave
    Hideake Miyake
    Uwe Zangemeister-Wittke
    Burkhard Jansen
    Cancer and Metastasis Reviews, 2002, 21 : 79 - 92
  • [49] Current status and prospects of androgen depletion therapy for prostate cancer
    Akaza, Hideyuki
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (02) : 293 - 302
  • [50] Antisense therapy: Current status in prostate cancer and other malignancies
    Gleave, M
    Miyake, H
    Zangemeister-Wittke, U
    Jansen, B
    CANCER AND METASTASIS REVIEWS, 2002, 21 (01) : 79 - 92